Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

CRNX
Crinetics Pharmaceuticals, Inc.US flagNASDAQ Global Select
35.60
USD
+1.13
- -
3.75BMarket Cap

Income Statement (USD)

MCPAPIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
5
4
1
8
+ Sales & Services Revenue
- -
- -
- -
- -
- -
1
5
4
1
8
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
Gross Profit
- -
- -
- -
- -
- -
- -
- -
4
1
7
+ Other Operating Income
- -
- -
- -
- -
- -
-1
-5
- -
- -
- -
- Operating Expenses
6
9
29
54
75
109
173
227
340
523
+ Selling, General & Admin
2
2
7
14
18
25
42
58
100
191
+ Research & Development
5
9
24
42
57
84
130
169
240
332
+ Other Operating Expense
-1
-2
-2
-1
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-6
-9
-29
-54
-75
-108
-168
-223
-339
-517
- Non-Operating (Income) Loss
- -
- -
-2
-3
-1
- -
-4
-8
-40
-52
+ Interest Expense, Net
- -
- -
-2
-3
-1
- -
-4
-13
-41
-52
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
2
3
1
- -
4
13
41
52
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
5
1
- -
Pretax Income
-6
-9
-27
-50
-74
-108
-164
-215
-298
-465
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-6
-9
-27
-50
-74
-108
-164
-215
-298
-465
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-6
-9
-27
-50
-74
-108
-164
-215
-298
-465
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-6
-9
-27
-50
-74
-108
-164
-215
-298
-465
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-6
-9
-27
-50
-74
-108
-164
-215
-298
-465
EBIT
-6
-9
-29
-54
-75
-108
-168
-223
-339
-517
EBITDA
-6
-9
-28
-53
-74
-107
-167
-222
-336
-513
EBITDA Margin (%)
- -
- -
- -
- -
- -
-9,905.38
-3,523.31
-5,519.81
-32,345.43
-6,664.23
EBITA
-6
-9
-29
-54
-75
-108
-168
-223
-339
-517
Gross Margin (%)
- -
- -
- -
- -
- -
100
100
100
100
86.02
Operating Margin (%)
- -
- -
- -
- -
- -
-9,990.91
-3,544.06
-5,547.17
-32,613.47
-6,714.77
Profit Margin (%)
- -
- -
- -
- -
- -
-9,985.25
-3,460.38
-5,345.85
-28,720.69
-6,046.22
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
1
1
1
1
3
4
Basic Weighted Avg Shares
14
14
12
24
30
38
52
58
81
94
Basic EPS, GAAP
-0.43
-0.66
-2.23
-2.09
-2.42
-2.8
-3.15
-3.69
-3.69
-4.95
Basic EPS from Cont Ops
-0.43
-0.66
-2.23
-2.09
-2.42
-2.8
-3.15
-3.69
-3.69
-4.95
Diluted Weighted Avg Shares
14
14
12
24
30
38
52
58
81
94
Diluted EPS, GAAP
-0.43
-0.66
-2.23
-2.09
-2.42
-2.8
-3.15
-3.69
-3.69
-4.95
Diluted EPS from Cont Ops
-0.43
-0.66
-2.23
-2.09
-2.42
-2.8
-3.15
-3.69
-3.69
-4.95

Balance Sheet (USD)

MCPAPIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
12
15
167
123
177
345
345
574
1,375
1,048
+ Cash, Cash Equivalents & STI
12
14
164
118
171
334
334
559
1,354
1,028
+ Cash & Cash Equivalents
12
14
45
40
93
201
33
55
265
102
+ ST Investments
- -
- -
119
78
78
133
302
504
1,090
926
+ Accounts & Notes Receiv
- -
1
2
1
2
2
3
9
- -
1
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
1
2
1
2
2
3
9
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
+ Other ST Assets
- -
- -
1
4
5
9
8
6
21
18
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
5
7
6
6
7
61
59
78
+ Property, Plant & Equip, Net
- -
- -
4
6
5
5
5
57
56
55
+ Property, Plant & Equip
- -
1
5
8
8
8
9
62
63
63
- Accumulated Depreciation
- -
- -
1
2
3
3
4
5
8
8
+ LT Investments & Receivables
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
1
1
1
2
3
4
23
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
1
1
1
2
3
4
23
Total Assets
13
16
171
130
183
351
352
635
1,435
1,126
+ Payables & Accruals
1
1
5
5
6
8
15
23
21
42
+ Accounts Payable
- -
- -
2
3
3
3
7
7
6
23
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
4
3
2
5
8
17
16
19
+ ST Debt
- -
- -
- -
- -
- -
- -
1
4
7
6
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
1
4
7
6
+ Other ST Liabilities
- -
- -
3
3
5
8
11
17
31
37
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
2
2
2
1
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
3
3
5
8
9
15
29
36
Total Current Liabilities
1
1
8
8
10
16
28
44
60
85
+ LT Debt
- -
- -
- -
5
4
3
2
48
45
42
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
5
4
3
2
48
45
42
+ Other LT Liabilities
18
30
3
- -
- -
- -
6
5
6
7
+ Accrued Liabilities
- -
- -
3
- -
- -
- -
6
5
5
4
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
18
30
- -
- -
- -
- -
- -
- -
1
3
Total Noncurrent Liabilities
18
30
3
5
4
3
8
52
50
49
Total Liabilities
19
31
11
13
15
19
36
96
110
134
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
1
407
211
337
608
759
1,192
2,276
2,408
+ Common Stock
- -
- -
204
211
337
608
759
1,192
2,276
2,408
+ Additional Paid in Capital
1
1
204
- -
- -
- -
- -
- -
- -
- -
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-7
-16
-43
-94
-168
-275
-439
-654
-952
-1,417
+ Other Equity
- -
- -
- -
- -
- -
- -
-4
1
1
2
Equity Before Minority Interest
-6
-15
160
117
169
332
316
539
1,325
992
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-6
-15
160
117
169
332
316
539
1,325
992
Total Liabilities & Equity
13
16
171
130
183
351
352
635
1,435
1,126
Shares Outstanding
22
22
24
24
33
48
54
68
93
96
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
5
4
3
3
52
52
49
Net Debt
-12
-14
-45
-40
-93
-201
-33
-55
-265
-102
Net Debt to Equity
192.46
94.47
-28.07
-34.43
-55.11
-60.46
-10.33
-10.18
-19.97
-10.23
Tangible Common Equity Ratio
-49.24
-96.31
93.47
89.85
92.08
94.57
89.82
84.85
92.35
88.09
Current Ratio
13.89
16.91
21.03
14.79
16.92
21.55
12.45
13.07
23.04
12.32
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,319.8

Cash Flow Statement (USD)

MCPAPIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-6
-9
-27
-50
-74
-108
-164
-215
-298
-465
+ Depreciation & Amortization
- -
- -
- -
1
1
1
1
1
3
4
+ Non-Cash Items
- -
- -
2
5
10
17
29
39
58
79
+ Stock-Based Compensation
- -
- -
2
6
10
17
28
41
69
91
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
-1
- -
- -
1
-2
-11
-12
+ Chg in Non-Cash Work Cap
- -
-1
5
-2
- -
1
19
6
7
5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
3
6
11
- -
- -
-1
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2
+ (Inc) Dec in Prepaid Assets
- -
-1
-2
-2
-2
-4
- -
-5
-6
-17
+ Inc (Dec) in Accts Payable
- -
- -
7
1
3
6
- -
12
13
29
+ Inc (Dec) in Other
- -
- -
- -
-1
-3
-7
7
-2
- -
-5
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-5
-9
-19
-46
-62
-89
-115
-169
-230
-378
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
- -
- -
- -
-2
-5
-4
-6
+ Acq of Fixed Prod Assets
- -
- -
-1
- -
- -
- -
-2
-5
-4
-6
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
106
- -
114
250
117
369
970
- -
+ Increase in Capital Stock
- -
- -
106
- -
114
250
117
370
985
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
-1
-15
- -
+ Net Change in LT Investment
- -
- -
-118
42
- -
-56
-172
-196
-571
180
+ Dec in LT Investment
- -
- -
- -
150
136
69
157
337
576
1,184
+ Inc in LT Investment
- -
- -
-118
-108
-136
-125
-330
-533
-1,147
-1,004
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-119
42
- -
-56
-174
-200
-575
174
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
12
64
- -
- -
3
5
22
45
41
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
12
170
- -
115
253
122
391
1,015
41
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-6
2
31
-5
53
108
-167
22
210
-163
EBITDA
-6
-9
-28
-53
-74
-107
-167
-222
-336
-513
EBITDA Margin (%)
- -
- -
- -
- -
- -
-9,905.38
-3,523.31
-5,519.81
-32,345.43
-6,664.23
Free Cash Flow
-6
-10
-21
-47
-62
-89
-117
-173
-234
-384
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-10
-21
-47
-62
-89
-117
-173
-234
-384
Free Cash Flow per Basic Share
-0.41
-0.7
-1.69
-1.94
-2.04
-2.32
-2.25
-2.98
-2.9
-4.08
Price/Free Cash Flow
- -
- -
-19.79
-13.22
-6.95
-12.39
-8.38
-12.61
-18.25
-11.76
Cash Flow to Net Income
0.91
1.04
0.72
0.92
0.84
0.82
0.7
0.79
0.77
0.81
Capital Expenditures
- -
- -
-1
- -
- -
- -
-2
-5
-4
-6